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ABSTRACT
Objectives We evaluated whether implementation of 
lockdown orders in South Africa affected ambulatory clinic 
visitation in rural Kwa- Zulu Natal (KZN).
Design Observational cohort
Setting Data were analysed from 11 primary healthcare 
clinics in northern KZN.
Participants A total of 46 523 individuals made 89 476 
clinic visits during the observation period.
Exposure of interest We conducted an interrupted time 
series analysis to estimate changes in clinic visitation with 
a focus on transitions from the prelockdown to the level 5, 
4 and 3 lockdown periods.
Outcome measures Daily clinic visitation at ambulatory 
clinics. In stratified analyses, we assessed visitation for the 
following subcategories: child health, perinatal care and 
family planning, HIV services, non- communicable diseases 
and by age and sex strata.
Results We found no change in total clinic visits/clinic/
day at the time of implementation of the level 5 lockdown 
(change from 90.3 to 84.6 mean visits/clinic/day, 95% CI 
−16.5 to 3.1), or at the transitions to less stringent level 4 
and 3 lockdown levels. We did detect a >50% reduction in 
child healthcare visits at the start of the level 5 lockdown 
from 11.9 to 4.7 visits/day (−7.1 visits/clinic/day, 95% CI 
−8.9 to 5.3), both for children aged <1 year and 1–5 years, 
with a gradual return to prelockdown within 3 months 
after the first lockdown measure. In contrast, we found no 
drop in clinic visitation in adults at the start of the level 5 
lockdown, or related to HIV care (from 37.5 to 45.6, 8.0 
visits/clinic/day, 95% CI 2.1 to 13.8).
Conclusions In rural KZN, we identified a significant, 
although temporary, reduction in child healthcare visitation 
but general resilience of adult ambulatory care provision 
during the first 4 months of the lockdown. Future work 
should explore the impacts of the circulating epidemic on 
primary care provision and long- term impacts of reduced 
child visitation on outcomes in the region.
INTRODUCTION
COVID-19 was declared a global pandemic by 
WHO on 11 March 2020, and it has spared 
no region of the world. Early in the epidemic, 
the greatest numbers of cases have been 
reported in Asia, Europe and North America, 
with more recent dissemination within Latin 
America and Africa.1 Although South Africa 
and a handful of other low- resource settings 
have reported widespread epidemics, limited 
testing and surveillance capabilities make it 
difficult to assess how widely the pandemic 
has spread in such settings. Such regions 
are believed to be at particular risk of severe 
epidemics, due to overcrowding, lower access 
to clean water and sanitation services and 
inherent shortages in health system infra-
structure for detection and management of 
disease.2–9
Strengths and limitations of this study
 ► This study is strengthened by a large number of 
observations per clinic, collection of data using re-
search staff and methods external to the program-
matic healthcare system (which can be interrupted 
during external shocks), and longitudinal obser-
vation allowing comparison of the preperiod and 
postperiod.
 ► The study was conducted within the public health 
sector of South Africa, and is generalisable to sim-
ilarly rural, resource- limited settings, and observa-
tion during the lockdown period prior to widespread 
local COVID-19 transmission.
 ► Our exposure of interest (ie, the lockdown mea-
sures) were not randomly allocated, so there is a 
risk, however small, that a simultaneous exogenous 
shock could be responsible for the changes in clinic 
visitation seen.
 ► The dataset is purely quantitative and focused on 
clinic visitation events, which prevents deeper ex-
ploration of the root causes of trends noted.
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In response, most nations in sub- Saharan Africa have 
implemented non- pharmacological interventions to 
attempt to prevent large- scale epidemics. These measures, 
which include restrictions on large gatherings, work and 
school attendance, travel and in their most stringent 
forms, shelter- in- place orders, are believed to reduce 
disease transmission.10–13 However, instituting these 
measures is also associated with deleterious economic 
and social, impacts, including large projected reductions 
in manufacturing, access to employment and basic neces-
sities and educational advancement; and these effects 
appear to be greatest among those in lower- income 
and vulnerability categories.14–19 Across the sub- Saharan 
African region, the Economic Commission for Africa proj-
ects an approximate 1.4% contraction in gross domestic 
product and that 25 million people are susceptible to 
entering extreme poverty.20 Some have hypothesised that 
non- pharmaceutical interventions might be less effective 
in settings with large informal economies and limited 
ability to respond to increases in cases of severe disease,21 
and that their risks might outweigh their benefits.22
Of particular concern is how social fear and reduced 
access to basic public health services might impact 
morbidity and mortality for non- COVID health condi-
tions. Modelling studies have suggested that even modest 
reductions in child healthcare access could result in 
100 000s of additional deaths in low- income and middle- 
income countries.23 Similar concerns have been raised 
by the Academy of Science of South Africa and others 
about provision of chronic disease care among adults.24 25 
UNAIDS has warned that non- pharmaceutical interven-
tions could challenge manufacturing and supply chains 
of HIV therapeutics,26 and modelling estimates suggest 
that such disruptions could cause as many if not more 
HIV- related deaths than COVID-19- related deaths.27 
Although empiric data on health outcomes remain 
sparse, there have been significant reductions in tubercu-
losis testing in South Africa during the early phases of the 
lockdown,28 indicating an interruption in critical services 
for the most common cause of death in the country.29 
There is also historical precedent from other recent 
communicable disease outbreaks. Primary healthcare 
access was significantly impacted during prior infectious 
disease epidemics, such as Ebola virus disease, resulting 
in increases in morbidity and mortality.30 31 Yet, whether 
and the extent to which similar effects will be seen during 
the COVID-19 epidemic is not known.
On 27 March 2020, South Africa instituted a nation-
wide shelter- in- place order, termed in South Africa as 
a level 5 lockdown. The level 5 order included closure 
of schools and all non- essential business, restrictions on 
public transport and restrictions on movement. Restric-
tions on movement during the level 5 lockdown specif-
ically required that individuals remain in their place of 
residence, with the exceptions of ‘performing an essential 
service, obtaining an essential good or service, collecting 
a social grant, pension, or seeking emergency, life- saving 
or chronic medical attention’. Over the following months, 
the restrictions gradually eased from level 5 down to 4 at 
the end of April and level 3 at the end of May, which corre-
sponded with lifting restrictions on intraprovince move-
ment, preinitiation of public transportation and allowed 
for reopening of schools and many business.32 33 Because 
the healthcare sector was deemed an essential service 
throughout the entire lockdown period, no restrictions 
were placed on access to or delivery of healthcare services.
We sought to assess the impact of these lockdown orders 
in response to the COVID-19 epidemic in South Africa on 
access to basic healthcare services. We analysed data on 
clinic visitation at 11 ambulatory public health clinics in 
northern KwaZulu- Natal, collected routinely as part of a 
demographic health and surveillance system (HDSS) by 
the Africa Health Research Institute (AHRI). We hypoth-
esised that there would be immediate and substantial 
reductions in clinic visitation after the institution of the 
lockdown measure, and that this would pertain to routine 
clinical care such as immunisations, perinatal care and 
chronic disease management in adults.
METHODS
Study setting
This analysis was conducted using data collected by the 
AHRI HDSS in the uMkhanyakude district of the KwaZulu- 
Natal Province. The HDSS comprises a complete census 
across a geographic area of approximately 850 km2; it is a 
rural region with a single peri- urban centre, KwaMsane, a 
town of approximately 30 000 residents. The region ranks 
among the lowest nationwide in terms of health indica-
tors and socioeconomic status.34 Approximately one in 
five adult men and two in five adult women are living with 
HIV.35 Tuberculosis incidence is among the highest in the 
world, and above the national average of 577 per 100 000 
individuals when last measured in 2015.36
Data collection
Since 2000 AHRI has collected data on births, deaths, 
migrations through thrice annual data collection encoun-
ters across a catchment area of 20 000 households (over 
100 000 resident individuals).34 In 2017, AHRI began 
placing clinic research assistants at each of the 11 govern-
ment- run public health clinics in the area. These research 
staff operate in partnership with the Department of 
Health, but outside of the standard Health Management 
Information System (HMIS). For each person who pres-
ents to clinic, they collect demographic information and 
the self- reported reason(s) for the clinical visit. We link 
data between the HDSS and the clinic medical record 
system electronically using a unifying identification code 
for each resident of the catchment area. For this analysis, 
we included all individuals who presented to ambulatory 
clinic in the 11 regional clinics in the study catchment 
area during our observation period. There were no age 
or sex exclusions. AHRI holds memoranda of under-
standing with the Provincial and District Department of 
Health that permit extraction of health record data from 
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primary care and hospital sites for linkage to the house-
hold surveillance dataset.
Study design
We conducted an interrupted time series analysis to esti-
mate changes in clinic visitation in rural KwaZulu- Natal 
before and after the national lockdown implementation 
on 27 March 2020. To do so, we fitted linear mixed effects 
regression models by restricted maximum likelihood with 
daily clinic visits as the primary outcome of interest. Our 
primary exposure of interest was time period, divided into 
four periods: (1) the prelockdown period starting 60 days 
prior to the initial level 5 lockdown until 27 March 2020; 
(2) the level 5 lockdown period from 28 March through 
30 April 2020; (3) the level 4 lockdown level from 1 May 
through 31 May and (4) the level 3 lockdown level from 
1 June through our data abstraction date (30 June). For 
our primary outcome, we estimated the stepwise change 
in mean visits per clinic on the date of implementation 
lockdown level.37 We included a fixed effect for day of the 
week, random clinic- specific intercepts and random clinic- 
specific slopes on time in our models. We excluded week-
ends because the study clinics do not provide non- urgent 
ambulatory care services on weekends. We excluded dates 
from observation when AHRI staff members who perform 
data capture for the clinic- link system were not working, 
including national holidays and staff trainings.
Our primary outcome of interest was the number of clinic 
visits for any reason per clinic. In secondary analyses, we 
stratified models by visit type restricted to: (1) child health 
visits (immunisations and growth monitoring); (2) ante-
natal care, postnatal care and family planning; (3) HIV 
services (including antiretroviral therapy initiation, antiret-
roviral therapy continuation and chronic care medical 
dispensing programme visits) and (4) chronic care of non- 
communicable diseases (hypertension and diabetes). Clinic 
visits for more than one reason were treated as visits for both 
conditions. We also conducted stratified analyses by age cate-
gory (<1, 1–5, 6–19, 20–45 and >45 years) and by women and 
men aged 15 years or older.
We performed a number of secondary and sensitivity anal-
yses to assess model validity and robustness of our findings. In 
addition to estimating stepwise changes after each lockdown 
order and change, we estimated trends in weekly visits during 
each period to determine whether immediate changes were 
sustained over each period. We graphically depicted the 
residuals in the model to assess the normality assumption 
of our linear model structure. To check the robustness of 
model assumptions about changes from the prelockdown to 
the level 5 lockdown periods, we conducted multiple sensi-
tivity analyses: (1) we specified a Poisson mixed effects regres-
sion model in place of a linear model; (2) we fitted linear 
and Poisson generalised estimating equation (GEE) models 
clustered by facility; (3) we specified an autoregressive cova-
riance structure in place of an exchangeable structure in the 
GEE models and (4) to assess for the possibility of seasonal 
changes over multiple years, we constructed locally weighted 
scatterplot smoothing (LOWESS) plots to visually inspect 
clinical visitation trends over the same observation periods in 
2020 vs 2018 and 2019 and fitted a difference- in- differences 
model that included year (2019 vs 2020) and time (charac-
terised as prelockdown vs level 5 lockdown) to assess whether 
changes before and after the level 5 lockdown differed by 
calendar year.
Finally, we conducted an additional sensitivity analysis to 
assess for the possibility of in- migration into the HDSS catch-
ment area during the lockdown period, which would poten-
tially bias clinic visitation frequency upwards. To do so, we 
calculated annual visitation frequency at the 11 area clinics 
for each individual in the dataset for the year prior to the 
lockdown. We then compared the median number of annual 
visits per individual in the prelockdown and postlockdown 
periods, and the number of individuals with exactly one visit 
in the past year in the two periods. If significant in- migration 
did occur during the lockdown period, we would expect that 
the median number of annual visits per individual would 
decrease during the lockdown, whereas the number of indi-
viduals with one visit in the past 12 months would increase.
Three study investigators designed a statistical plan 
prior to all analyses (MJS, JDK, MJM). The initial analysis 
plan included fitting mixed effects models with random 
effects by clinic and inspecting trends in clinic visita-
tion changes from the prelockdown to level 5 lockdown 
period for the overall cohort, and by visit subtype. We also 
initially included plans for sensitivity analyses, including 
fitting of generalised estimating equations and additions 
of random slopes to our models as robustness checks. In 
response to reviewer requests and with updates to the 
lockdown characteristics from levels 5 to 4 to 3 during the 
review process, we conducted a number of post hoc anal-
yses, including construction of LOWESS plots and fitting 
additional models to assess for seasonal trends in visita-
tion by year, and fitting mixed effects Poisson models. All 
statistical analyses were conducted using Stata and R.
Patient and public involvement
This protocol was reviewed and approved by the AHRI 
Community Advisory Board, who contributed to the study 
design and selection of collection measures. Results of 
studies from the HDSS project are routinely shared with 
the community through public communications and 
road shows conducted by the AHRI Public Engagement 
Department. Final, all study protocols are reviewed and 
approved by the District and Provincial Department of 
Health, and AHRI holds memoranda of understanding 
with the Provincial and District Departments of Health 
that outline methods of extraction of health record data 
from primary care sites for linkage to the household 
surveillance dataset.
RESULTS
A total of 46 523 individuals made 89 476 clinic visits 
between 27 January and 30 June 2020 at the 11 area 
clinics (table 1). Women and girls accounted for 67% 
(n=64 125) of visits. Approximately 9% of visits were 
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made by individuals <1 year of age (n=4186), 1–5 years 
of age (n=3944) and 6–19 years of age (n=4460), respec-
tively; whereas those aged 20–45 years accounted for 48% 
(n=22 231) and those over 46 years the remaining 25% of 
visits (n=11 702). The most common reason for a clinic 
visit was ART follow- up care, comprising 43% of all visits 
(n=38 142), followed by visits for minor ailments (18%, 
n=16 204), child health (n=9672, 11%) and hypertension 
(n=9273, n=10%).
There was an average of 90.3 (95% CI 67.5 to 113.2) 
clinic visits per day per clinic in the prelockdown period. 
We identified a non- significant drop in visits immediately 
following the start of the level 5 lockdown (−6.7 visits/
clinic/day, 95% CI −16.5 to 3.1). The small reduction seen 
after the level 5 period was reversed by a non- significant 
stepwise increase between the level 5 and level 4 periods 
(increase of 11.2 visits/clinic/day, 95% CI −0.5 to 23.0), 
and persistent clinic visitation between the end of level 4 
and the start of the level 3 period (increase of 1.2 visits/
clinic/day, 95% CI −9.7 to 12.1) (table 2, figure 1). There 
were no significant changes in trends over time in clinic 
visits/week in any of the preimplementation or postim-
plementation periods (online supplemental table 1).
In contrast, child health visits suffered a 60% step-
wise drop at the initiation of the level 5 lockdown (from 
11.9 to 4.6 visits/day/clinic, mean change of −7.1 visits, 
95% CI −9.0 to 5.3), but remained steady during the tran-
sition between the level 5 and level 4 (−0.5 visits/clinic/
day, 95% CI −2.7 to 1.7), and again between the level 4 
and level 3 lockdowns (−0.4 visits/clinic/day, 95% CI 
−2.5 to 1.6) (table 2, figure 1). The reduction in child 
visits at the time of the level 5 lockdown occurred both 
among children under 1 (mean decrease of −5.4 visits, 
95% CI −7.0 to 3.7) and those 1–5 years of age (mean 
decrease of −5.5 visits, 95% CI −6.7 to 4.4). We did detect 
fluctuating trends in child visitation during the lockdown 
periods, with increases of approximately one visit/clinic/
week in levels 5 and 3, resulting in a similar number of 
mean visits/clinic/day 1 month into to the level 3 lock-
down on 30 June as compared with just prior to the level 
5 lockdown (11.2 visits/clinic/day (95% CI 7.4 to 14.8) vs 
11.9 visits/clinic/day (95% CI 8.6 to 15.1), online supple-
mental table 1).
In contrast to child health visits, HIV- related clinical 
visits for adults did not decrease between the prelockdown 
and level 5 lockdown period from 37.6 visits/clinic/day to 
45.5 visits/clinic/day (mean change of 7.9 visits/clinic/
day, 95% CI 2.1 to 13.8), between the level 5 lockdown 
and level 4 lockdown period (increase of 11.1 clinic/
visits/day, 95% CI 4.1 to 18.0) or between the transition 
from the level 4 to level 3 (increase of 4.0 visits/clinic/
day, 95% CI −2.5 to 10.5) (table 2, figure 1). We similarly 
identified resilience in family planning visits over the 
observation period, increasing from 7.3 visits/clinic/day 
in the preimplementation period to 7.8 visits/clinic/day 
after transition to level 5 (+0.5 visits/clinic/day, 95% CI 
−1.0 to 2.0) to 8.9 clinic visits/day after transition to level 4 
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clinic/day after transition to level 3 (+2.0 visits/clinic/
day, 95% CI 0.3 to 3.7) for a 66% total increase from the 
preperiod. We did not detect changes in clinic visitation 
for chronic non- communicable diseases, or more broadly 
in clinic visitation by men or women 15 years or older.
Graphical depictions of residuals from our linear 
models demonstrated normally distributed residuals for 
the total visit, HIV and child visit models, supporting the 
specification of a linear model to estimate trends in clinic 
visitation (online supplemental figure 1). We found no 
evidence of changes in clinic visitation during this same 
period in 2019 to suggest seasonal effects, either graphi-
cally in LOWESS plots, or in difference- in- differences in 
models including both 2019 and 2020 with prelockdown 
and postlockdown periods (table 3, online supplemental 
figure 2). Results were robust to modelling assumptions 
in the sensitivity analyses (table 3).
Finally, we did not detect evidence of meaningful 
in- migration during the lockdown period. The median 
number of visits in the past year per individual attending 
the clinic slightly increased from the prelockdown period 
to the lockdown period (mean 5.8 (SD 0.02) vs 5.9 (SD 
0.03), p<0.001). This pattern was similar among people 
attending clinic for HIV- specific visits (mean 6.5 (SD 
0.02) vs mean 6.6 (SD 0.04), p=0.01). The number of 
people with exactly one visit in the past year also did not 
meaningfully increase during the observation period with 
1960 (February), 2115 (March), 1573 (April), 1893 (May) 
and 1986 (June) visits made by individuals with exactly 
one annual clinic visit over the prior 12 months.
DISCUSSION
We found evidence of a significant drop in visits for 
childcare alongside sustained visitation in HIV and adult 
ambulatory clinic utilisation in a rural area of South 
Africa during the national lockdown for the COVID-19 
epidemic. Notably, visits for chronic disease, such as 
hypertension and diabetes, perinatal care and family 
planning remained reasonably constant or modestly 
increased. However, child health visits for immunisa-
tions and growth monitoring dropped immediately by 
over 50% after the start of the lockdown. With gradual 
increases over time during level 5 and level 3 lockdown, 
child visits largely returned to prelockdown levels in June, 
approximately 3 months after the lockdown began. We 
noted an estimated 20% increase in clinic visits for HIV 
immediately after the lockdown and suspect this might 
have reflected an urgency to collect medications prior 
to an anticipated interruption in clinic access or medica-
tion availability and/or national programmatic efforts to 
accelerate transitions to a new first- line regimen.38 These 
results demonstrate concerning trends about reductions 
in preventative child care during the lockdown period. 
However, they also appeared to disprove our hypothesis 
about clinic visitation in adults, and potentially demon-
strate a resilience in the healthcare sector during a period 
of concern for access to chronic and essential basic health 
services.
The key demographic population in our study that 
experienced significant drops in clinic visitation was 
children. Child health visits appeared to have modestly 
rebounded during the lockdown, and eventually return 
to their prelockdown state. Although these data do 
not suggest the cause of reduced visitation in children, 
multiple possible factors might be considered. We hypoth-
esise that limited options for childcare for families with 
multiple children might prevent caregivers from being 
able to bring individual children to clinic. Moreover, in 
Figure 1 Ambulatory clinic visitation before and after the nationwide lockdown in South Africa at 11 outpatient clinics in rural 
uMkhanyakude District, KwaZulu- Natal South Africa. Scatter plots represent mean clinic visitation at each clinic on weekdays 
during the observation period. The black fit line represents the mean visitation across all clinics estimated by postregression 
margins from a linear regression model, with a regression discontinuity coefficient at the date of the lockdown (27 March 2020, 
red line). Grey bars represent 95% CIs. The dotted blue line represents the geometic mean of the number of visits across all 
clinics on each day.
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contrast to, for example, HIV wellcare visits, well child 
visits rarely involve medication refills so might be priori-
tised lower for families. Whatever the cause, our findings 
are in keeping with data from elsewhere. In Hangzhou, 
China, paediatric healthcare visits dropped by nearly 75% 
during the peak of the epidemic and lockdown periods.39 
In the USA, vaccination rates in children substantially 
declined after a national emergency was declared in 
response to the COVID-19 epidemic.40 Modelling anal-
yses using Lived Saves Tool have suggested that a 15% 
reduction in maternal and child health coverage could 
result in over 250 000 additional deaths.23 WHO has also 
projected significant increases in deaths due to malaria 
in children under 5 in endemic regions with disruptions 
in malaria care and insecticide- treated bednet distribu-
tion.41 Although empiric data on healthcare access in 
South Africa remain scarce, work to date has suggested 
significant reductions in tuberculosis testing in labora-
tory databases, and reports of interruptions in care in 
community- based surveys.28 42 Previous disease epidemics 
in sub- Saharan Africa have also been associated with 
lapses in primary care access, and drops in facility based 
births and child healthcare access.30 31 43 44 Consequently, 
future work should investigate the impacts of even modest 
drops in vaccination rates and child health outcomes, 
to better assess whether the drop we identified resulted 
in long- term health effects, and whether catch- up vacci-
nation campaigns might help limit the fallout of such 
interruptions.45
Maintaining healthcare access during the epidemic 
requires a careful balance of primary healthcare provision 
and protection of vulnerable populations from COVID-19 
infection. In other settings, there have been multiple 
reports of late and severe presentations to care for non- 
COVID-19 conditions, putatively due to decreased access 
to care or fear of nosocomial infection at healthcare facil-
ities.46–48 At the time of our data abstraction at the end 
of June during the level 3 lockdown period, fewer than 
Table 3 Sensitivity analyses, demonstrating results of the main regression model and alternate models
All visits
Mean daily visits per clinic 
at time of lockdown period
Stepwise change in clinic 
visits/day at start of level 5 
lockdown P value
Primary model 90.3 (67.1 to 113.5) −6.7 (−16.4 to 3.0) 0.18
Poisson* mixed effects model 92.0 (59.3 to 124.7) −6.9 (−11.0 to −2.8) 0.001
Linear GEE (exchangeable correlation matrix) 89.2 (67.0 to 111.4) −6.4 (−16.8 to 4.08) 0.23
Poisson GEE* (exchangeable correlation matrix) 89.2 (84.7 to 93.6) −6.6 (−8.7 to −4.5) <0.001
Linear GEE (autoregressive correlation matrix) 90.2 (73.2 to 107.2) −5.4 (−27.4 to 16.6) 0.63
Poisson GEE* (autoregressive correlation matrix) 88.4 (85.0 to 91.9) −5.0 (−9.4 to −0.6) 0.03
Difference- in- differences† 96.3 (63.6 to 129.0) 3.4 (−5.5 to 12.4) 0.45
Childcare visits
  Primary model 11.9 (8.6 to 15.1) −7.1 (−8.9 to −5.3) <0.001
  Poisson* mixed effects model 12.3 (7.1 to 17.5) −7.7 (−11.1 to −4.4) <0.001
  Linear GEE (exchangeable correlation matrix) 11.8 (8.6 to 15.0) −7.1 (−9.0 to −5.2) <0.001
  Poisson GEE* (exchangeable correlation matrix) 12.0 (10.5 to 13.5) −7.5 (−8.4 to −6.6) <0.001
  Linear GEE (autoregressive correlation matrix) 11.9 (9.5 to 14.4) −6.4 (−9.9 to −2.9) <0.001
  Poisson GEE* (autoregressive correlation matrix) 11.9 (10.7 to 13.1) −6.7 (−8.1 to −5.4) <0.001
  Difference- in- differences† 11.8 (8.0 to 15.7) −4.0 (−5.5 to −2.5) <0.001
HIV visits
  Primary model 37.5 (24.4 to 50.7) 8.0 (2.3 to 13.7) 0.01
  Poisson* mixed effects model 39.2 (22.7 to 55.8) 9.0 (4.5 to 13.5) <0.001
  Linear GEE (exchangeable correlation matrix) 37.7 (25.3 to 50.1) 8.1 (2.2 to 14.0) 0.007
  Poisson GEE* (exchangeable correlation matrix) 37.7 (34.8 to 40.6) 8.7 (7.2 to 10.3) <0.001
  Linear GEE (autoregressive correlation matrix) 38.9 (29.3 to 48.5) 6.1 (−6.2 to 18.5) 0.33
  Poisson GEE* (autoregressive correlation matrix) 37.9 (35.7 to 40.1) 5.7 (2.6 to 8.8) 0.002
  Difference- in- differences† 43.6 (25.1 to 62.1) 4.8 (−0.5 to 10.1) 0.08
*Poisson GEE results are presented as predictive margins and marginal effects so they represent changes on the same additive scale as the 
linear models.
†Difference- in- differences estimates are estimated as the mean of the level 5 lockdown period minus the mean of the prelockdown period, 
comparing 2020 with 2019. Estimates are based on a period- by- year interaction term fit via linear mixed models.
.GEE, generalised estimating equations.
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200 cases of COVID-19 infection had been reported in 
uMkhanyakude District.49 Thus, our data largely reflect 
impacts of lockdown measures prior to an epidemic 
with significant local transmission. Clinics in this district 
instituted symptom screening at the entryway to clinics, 
with referral of individuals meeting criteria for persons 
under investigation to regional COVID-19 testing centres. 
Future work should revisit the impacts of the epidemic 
itself on access to primary healthcare.
The COVID-19 epidemic has also led to calls for decen-
tralised care to minimise exposure for high- risk popula-
tions,50 including those with chronic non- communicable 
disease, HIV, a history of tuberculosis- related lung disease 
and those of older ages. The lockdown was instituted 
rapidly in South Africa, before substantial decentralised 
care systems could be put in place. However, an important 
unanswered question is how such programmes will affect 
access to care and epidemic transmission in high- risk 
populations, including the elderly and those with immu-
nosuppressing conditions.
Our study should be interpreted within the context of 
the relatively short period (3 months) of the lockdown 
in South Africa. As a result, we are not yet able to assess 
long- term repercussions from disruptions to income or 
from the epidemic itself, or long- term effects of lapses in 
primary care and vaccination on health outcomes, and 
our results should not be generalised over longer time 
horizons. It is expected that economic barriers to health-
care utilisation will increase as the epidemic’s effects 
persist over time, including secondary effects from non- 
pharmaceutical interventions. These effects are likely 
to fall most heavily on those in the informal economy.51 
South Africa has taken steps to increase social support to 
counteract economic disruption from the epidemic and 
control measures.52 Mitigating long- term consequences 
may require governments and development partners to 
increase access to employment and other social support 
services during the epidemic.
Our study had multiple strengths. First, our data collec-
tion procedures are led by research staff who remained 
in place during the lockdown period, so these data are 
not affected by barriers to data collection (eg, interrup-
tions in staff transportation or workplace access). This is 
important, since many routine health information systems 
could be expected to suffer lapses during external shocks 
to the healthcare system. Second, our study was able to 
access data collected across 11 clinical centres within a 
large HDSS, which provided significant power to detect 
even small interruptions to healthcare access. A key 
potential limitation to our study is that it is predicated on 
the assumption that there were no other external factors 
that would have caused interruptions to the healthcare 
system on or after 27 March 2020 (eg, power outage, 
inclement weather). We are unaware of any such shock 
and believe this to be a minor risk. We saw no evidence of 
a seasonal effect after comparing our results with similar 
time periods in 2019. Our analysis should also be inter-
preted within the context of our study area—one with 
approximately 200 reported cases of COVID-19 at the 
time of the analysis, but in a nation with a large epidemic 
(approximately 200 000 cases as of early July) with estab-
lished local transmission in other areas.
In summary, we report a reduction in child wellcare visi-
tation but resilience of the adult ambulatory healthcare 
system during the early COVID-19 epidemic and lock-
down period in rural South Africa. Future work should 
establish if these trends are maintained, and particu-
larly monitor access to childcare and immunisations as 
a result of the trends reported in this study. Finally, in 
rural South Africa and similar areas, efforts to balance 
ongoing provision of essential preventative and chronic 
healthcare services might be needed to ensure healthcare 
access remains intact while preventing nosocomial spread 
of COVID-19 among high- risk populations.
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